Regeneron Pharmaceuticals Inc (REGN)
744.42
+1.07
(+0.14%)
USD |
NASDAQ |
Nov 21, 16:00
746.00
+1.58
(+0.21%)
After-Hours: 16:47
Regeneron Pharmaceuticals Market Cap: 81.80B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 81.69B |
| November 19, 2024 | 81.82B |
| November 18, 2024 | 83.74B |
| November 15, 2024 | 83.17B |
| November 14, 2024 | 85.99B |
| November 13, 2024 | 88.39B |
| November 12, 2024 | 90.22B |
| November 11, 2024 | 90.73B |
| November 08, 2024 | 91.03B |
| November 07, 2024 | 90.60B |
| November 06, 2024 | 89.74B |
| November 05, 2024 | 91.15B |
| November 04, 2024 | 91.08B |
| November 01, 2024 | 92.70B |
| October 31, 2024 | 92.11B |
| October 30, 2024 | 101.40B |
| October 29, 2024 | 101.90B |
| October 28, 2024 | 102.04B |
| October 25, 2024 | 102.53B |
| October 24, 2024 | 102.08B |
| October 23, 2024 | 103.45B |
| October 22, 2024 | 105.97B |
| October 21, 2024 | 106.65B |
| October 18, 2024 | 109.09B |
| October 17, 2024 | 109.92B |
| Date | Value |
|---|---|
| October 16, 2024 | 110.99B |
| October 15, 2024 | 111.94B |
| October 14, 2024 | 111.69B |
| October 11, 2024 | 111.84B |
| October 10, 2024 | 110.01B |
| October 09, 2024 | 111.46B |
| October 08, 2024 | 110.70B |
| October 07, 2024 | 109.68B |
| October 04, 2024 | 111.53B |
| October 03, 2024 | 111.72B |
| October 02, 2024 | 114.55B |
| October 01, 2024 | 115.28B |
| September 30, 2024 | 115.76B |
| September 27, 2024 | 114.94B |
| September 26, 2024 | 114.64B |
| September 25, 2024 | 113.67B |
| September 24, 2024 | 115.30B |
| September 23, 2024 | 120.37B |
| September 20, 2024 | 126.22B |
| September 19, 2024 | 126.79B |
| September 18, 2024 | 125.54B |
| September 17, 2024 | 126.41B |
| September 16, 2024 | 127.11B |
| September 13, 2024 | 127.14B |
| September 12, 2024 | 128.36B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.07B
Minimum
Jan 30 2020
132.48B
Maximum
Aug 27 2024
75.41B
Average
70.13B
Median
Nov 03 2021
Market Cap Benchmarks
| Amgen Inc | 155.82B |
| Eli Lilly and Co | 711.90B |
| Pfizer Inc | 142.44B |
| Biogen Inc | 23.00B |
| AbbVie Inc | 303.42B |
Market Cap Related Metrics
| PE Ratio | 18.42 |
| PS Ratio | 6.188 |
| PEG Ratio | 1.207 |
| Price to Book Value | 2.790 |
| Price to Free Cash Flow | 25.81 |
| Price | 744.42 |
| Earnings Yield | 5.43% |
| PEGY Ratio | 1.207 |
| Operating PE Ratio | 20.95 |
| Normalized PE Ratio | 19.44 |